loadpatents
Patent applications and USPTO patent grants for Bard; Frederique.The latest application filed is for "anti-abeta antibodies".
Patent | Date |
---|---|
Anti-abeta antibodies Grant 11,440,953 - Skov , et al. September 13, 2 | 2022-09-13 |
Anti-Abeta antibodies Grant 11,434,285 - Skov , et al. September 6, 2 | 2022-09-06 |
Anti-abeta antibodies Grant 11,434,283 - Skov , et al. September 6, 2 | 2022-09-06 |
Anti-Abeta antibodies Grant 11,434,284 - Skov , et al. September 6, 2 | 2022-09-06 |
Anti-Abeta Antibodies App 20220242940 - SKOV; Michael ;   et al. | 2022-08-04 |
Anti-Abeta Antibodies App 20220089762 - SKOV; Michael ;   et al. | 2022-03-24 |
Anti-Abeta Antibodies App 20220049009 - SKOV; Michael ;   et al. | 2022-02-17 |
Anti-Abeta Antibodies App 20220041699 - SKOV; Michael ;   et al. | 2022-02-10 |
Anti-Abeta Antibodies App 20220041700 - SKOV; Michael ;   et al. | 2022-02-10 |
Anti-Abeta Antibodies App 20220041701 - SKOV; Michael ;   et al. | 2022-02-10 |
Humanized antibodies that recognize beta amyloid peptide Grant 7,871,615 - Basi , et al. January 18, 2 | 2011-01-18 |
Method of screening an antibody for activity in clearing an amyloid deposit Grant 7,575,880 - Schenk , et al. August 18, 2 | 2009-08-18 |
Active Immunization To Generate Antibodies To Soluble A-beta App 20080279873 - Seubert; Peter A. ;   et al. | 2008-11-13 |
Prevention and treatment of amyloidogenic disease App 20060121038 - Schenk; Dale B. ;   et al. | 2006-06-08 |
Prevention and treatment of amyloidogenic disease App 20050158304 - Schenk, Dale B. ;   et al. | 2005-07-21 |
Prevention and treatment of amyloidogenic disease App 20050142132 - Schenk, Dale B. ;   et al. | 2005-06-30 |
Prevention and treatment of amyloidogenic disease App 20050123544 - Schenk, Dale B. ;   et al. | 2005-06-09 |
Humanized antibodies that recognize beta amyloid peptide App 20050118651 - Basi, Guriq ;   et al. | 2005-06-02 |
Prevention and treatment of amyloidogenic disease App 20050059802 - Schenk, Dale B. ;   et al. | 2005-03-17 |
Prevention and treatment of amyloidogenic disease App 20040265301 - Schenk, Dale B. ;   et al. | 2004-12-30 |
Prevention and treatment of amyloidogenic disease App 20040247591 - Schenk, Dale B. ;   et al. | 2004-12-09 |
Prevention and treatment of amyloidogenic disease App 20040247590 - Schenk, Dale B. ;   et al. | 2004-12-09 |
Screening markers and methods for neurodegenerative disorders App 20040213739 - McConlogue, Lisa C. ;   et al. | 2004-10-28 |
Active immunization to generate antibodies to soluble A-beta App 20040213800 - Seubert, Peter A. ;   et al. | 2004-10-28 |
Humanized and chimeric N-terminal amyloid beta-antibodies Grant 6,750,324 - Schenk , et al. June 15, 2 | 2004-06-15 |
Selecting compounds to reduce inflammation associated with Alzheimer's disease Grant 6,664,442 - McConlogue , et al. December 16, 2 | 2003-12-16 |
Screening markers and methods for neurodegenerative disorders App 20020147998 - McConlogue, Lisa C. ;   et al. | 2002-10-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.